By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Korean molecular diagnostics firm Seegene today said it has raised $16.6 million in its initial public offering.

The company said it had sold 636,500 shares of its stock on the KOSDAQ (Korea Securities Dealers Automated Quotations) at KRW30,500 ($26.16) per share, and now has a market capitalization of $167 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.